Glutamine protects intestinal immunity through microbial metabolites rather than microbiota

Area of Science:

• Immunology
• Microbiology
• Metabolomics

Background:

• Glutamine exhibits anti-inflammatory properties and maintains intestinal barrier integrity.
• Previous research indicated glutamine promotes secretory immunoglobulin A (SIgA) synthesis via gut microbiota.
• The current study aimed to elucidate the role of gut microbiota or their metabolites in regulating SIgA synthesis.

Purpose of the Study:

• To investigate whether gut microbiota or microbial metabolites regulate SIgA synthesis.
• To analyze metabolic changes in intestinal luminal contents following glutamine supplementation.
• To identify specific metabolic pathways and differential metabolites influenced by glutamine.

Main Methods:

• Untargeted metabolomics techniques were employed to analyze intestinal luminal contents.
• Samples from glutamine-supplemented and control groups were compared.
• KEGG pathway analysis was used to identify affected metabolic pathways.

Main Results:

• Glutamine supplementation did not significantly alter the intestinal microbiota composition.
• Metabolomics revealed significant differences in microbial metabolites, with numerous up- and down-regulated compounds.
• Key affected pathways included propionic acid metabolism, TCA cycle, and nitrogen metabolism, involving metabolites like bile secretion and diterpenoids.

Conclusions:

• Glutamine supplementation influences intestinal immunity and development through modulation of microbial metabolites.
• These metabolic changes contribute to maintaining intestinal homeostasis.
• Glutamine may improve intestinal immunity by altering the gut microbial metabolic profile.